Release date: 17 September 2013
Promoter – Financial Intermediary
IMPERIAL INNOVATIONS GROUP PLCLocation
Description
The project will support the research and the commercialisation of intellectual property generated from leading UK universities. It concerns the investments into the life science sector by the promoter.
Objectives
The project will range from pre-seed and seed financing and proof of concept studies to the financing of pre-clinical and clinical trials of the enterprises.
Comments
The Risk Sharing Finance Facility (RSFF) is an innovative credit risk sharing scheme jointly set up by the European Commission and the European Investment Bank to improve access to debt financing for private companies or public institutions promoting activities with a higher financial risk profile in the fields of research, technological development, demonstration and innovation investments.
Sector(s)
Proposed EIB finance (Approximate amount)
EUR 37 million (GBP 30 million)
Total cost (Approximate amount)
EUR 115 million (GBP 93 million)
Environmental aspects
R&D activities included in the project will not materially change current R&D practice and will be carried out within existing facilities making use of existing laboratories, pilot plants, clinical centres etc. An Environmental Impact Assessment (EIA) by a competent authority according to the Directive 2011/92/EU should not be required.
Procurement
The promoter is a private company not operating in the utilities sector and is thus not covered by EU Directives on procurement.
Status
Signed - 1/07/2013
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).